Product Code: ETC6192571 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Australias targeted sequencing and resequencing market is expanding due to rising applications in cancer genomics, rare disease research, and pharmacogenomics. Advanced sequencing platforms, government genomics programs, and a skilled research workforce are supporting market growth across clinical and academic segments.
The targeted sequencing and resequencing market is expanding due to its applications in clinical diagnostics, agriculture, and research. With decreasing sequencing costs and improved accuracy, laboratories across Australia are adopting targeted panels for inherited diseases, cancer profiling, and pathogen identification. Demand for automation and scalable platforms is also rising.
This market faces limitations due to the need for high-throughput sequencing platforms, substantial bioinformatics support, and cost-effective protocols. Hospitals and diagnostic centers often lack the resources to implement targeted sequencing efficiently. Moreover, privacy concerns around genetic data, combined with inconsistent insurance coverage, reduce patient participation and slow market adoption.
Targeted sequencing technologies are increasingly applied in disease diagnostics, forensics, and genetic research. Investment opportunities exist in sequencing platform development, reagent manufacturing, and genomic data analytics. Expansion into clinical diagnostic services using targeted resequencing methods is a growing segment with strong potential.
Government policies in genomics and precision medicine play a crucial role in the growth of this market. The Australian Government funds targeted sequencing initiatives under national health genomics plans and supports the integration of these technologies into clinical settings. Regulatory frameworks ensure ethical data usage and patient consent, while infrastructure investments enhance accessibility to advanced sequencing platforms across public hospitals and research institutions.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Targeted Sequencing and Resequencing Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Targeted Sequencing and Resequencing Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Targeted Sequencing and Resequencing Market - Industry Life Cycle |
3.4 Australia Targeted Sequencing and Resequencing Market - Porter's Five Forces |
3.5 Australia Targeted Sequencing and Resequencing Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Australia Targeted Sequencing and Resequencing Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Australia Targeted Sequencing and Resequencing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for personalized medicine and precision healthcare |
4.2.2 Technological advancements in sequencing technologies |
4.2.3 Growing research and development activities in genomics and biotechnology sectors |
4.3 Market Restraints |
4.3.1 High cost associated with targeted sequencing and resequencing technologies |
4.3.2 Data privacy and security concerns related to genetic information |
4.3.3 Lack of standardized protocols and regulatory challenges |
5 Australia Targeted Sequencing and Resequencing Market Trends |
6 Australia Targeted Sequencing and Resequencing Market, By Types |
6.1 Australia Targeted Sequencing and Resequencing Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Australia Targeted Sequencing and Resequencing Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Australia Targeted Sequencing and Resequencing Market Revenues & Volume, By DNA-based Targeted Sequencing, 2021- 2031F |
6.1.4 Australia Targeted Sequencing and Resequencing Market Revenues & Volume, By RNA-based Targeted Sequencing, 2021- 2031F |
6.2 Australia Targeted Sequencing and Resequencing Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Australia Targeted Sequencing and Resequencing Market Revenues & Volume, By Clinical Application, 2021- 2031F |
6.2.3 Australia Targeted Sequencing and Resequencing Market Revenues & Volume, By Plant and Animal Sciences, 2021- 2031F |
6.2.4 Australia Targeted Sequencing and Resequencing Market Revenues & Volume, By Drug Development, 2021- 2031F |
6.2.5 Australia Targeted Sequencing and Resequencing Market Revenues & Volume, By Others, 2021- 2031F |
7 Australia Targeted Sequencing and Resequencing Market Import-Export Trade Statistics |
7.1 Australia Targeted Sequencing and Resequencing Market Export to Major Countries |
7.2 Australia Targeted Sequencing and Resequencing Market Imports from Major Countries |
8 Australia Targeted Sequencing and Resequencing Market Key Performance Indicators |
8.1 Adoption rate of targeted sequencing and resequencing technologies in clinical settings |
8.2 Number of research collaborations and partnerships in genomics and biotechnology sectors |
8.3 Rate of incorporation of new sequencing technologies in diagnostic applications |
8.4 Frequency of updates and advancements in sequencing platforms and analysis tools |
8.5 Percentage of funding allocated to genomics research and development initiatives |
9 Australia Targeted Sequencing and Resequencing Market - Opportunity Assessment |
9.1 Australia Targeted Sequencing and Resequencing Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Australia Targeted Sequencing and Resequencing Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Australia Targeted Sequencing and Resequencing Market - Competitive Landscape |
10.1 Australia Targeted Sequencing and Resequencing Market Revenue Share, By Companies, 2024 |
10.2 Australia Targeted Sequencing and Resequencing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |